source
- FDA claims trial 'manipulation' tainted approval of ChemoCentryx drugThe FDA accused ChemoCentryx of manipulating the results of a pivotal clinical trial used to approve the drug Tavneos, escalating the agency's effort to pull the treatment from the market. "New inf…Endpoints · 3mo ago↗ source
- Devoted Health’s 2025 revenue slips in turbulent Medicare Advantage marketDevoted Health’s revenue and membership declined in 2025 for the first time since it launched health plans for seniors seven years ago. It’s a sign the high-profile startup, helmed by former Athena…Endpoints · 3mo ago↗ source
- Coultreon banks $125M to support testing of former Galapagos immune drugBacked by Novo Holdings, Regeneron’s venture arm and several others, the biotech believes an oral drug licensed from Galapagos might hold potential treating many immunological diseases.